To study whether serum iron metabolism markers including NTBI is related to mortality in HD patients.

To study whether serum iron metabolism markers including NTBI is related to mortality in HD patients. - To study whether serum iron metabolism markers including NTBI is related to mortality in HD patients.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1090220403

Enrollment

300

Registered

2018-12-20

Start date

2018-04-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodialysis patients

Interventions

Intervention type: Name of intervention: Dose form / Japanese Medical Device Nomenclature: Route of administration / Site of application: Dose per administration: Dosing frequency / Frequency of use:

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Hemodialysis patients

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
All cause mortality	—

Secondary

Measure	Time frame
Admission for newly onset of CVD and infectious disease.	—

Countries

Japan

Contacts

Public ContactShigeru Miyazaki

Shinraku-en Hospital

byori@shinrakuen.com+81-25-260-2608200

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026